DRUG FORMULATION

DRUG FORMULATION

DATA INTEGRITY

GLOBAL COMPLIANCE

QUALITY ASSURANCE

DRUG FORMULATION PROCESS

Pharmaceutically active molecules are rarely administered as a pure chemical but combined with various excipients into a formulation that is designed to ensure that the active ingredient is delivered in a safe, effective, and reproducible manner as possible. Solid dosage forms for oral administration are the most common formulations, but formulations may also be liquid or semi-solid depending on the routes of administration and therapeutic indications.

Excipients, although considered to be essentially chemically inert, have specific functionality within a formulation. Constituents added to a formulation that has no specific functionality are considered to be adulterants. For solid dosage forms, excipients might be added as lubricants, binders, disintegrators, appearance enhancers as well as for identification purposes and other functions. Solid dosage forms may also be coated to maintain long-term stability and improve bioavailability. Capsules typically made from either hard or soft gelatin offer an alternate solid form formulation pathway. Capsules can be filled with powder blends, granules, or pellets, depending on the targeted release profile.
For solid dosage forms, the target formulation criteria typically ease of manufacture to give appropriate solubility and dissolution of the active molecule for a consistent and reliable therapeutic response in the patient. These formulation criteria may require substantially different formulation strategies for different polymorphs and salt forms. For example, the enhanced solubility and dissolution rate that can be achieved with some salt and amorphous actives can lead to nucleation and recrystallization within the gut and reduced bioavailability. Formulations using solid forms with fast dissolution rates may include surfactants as excipients to inhibit nucleation. This formulation approach is often referred to as springs and parachutes.

As active molecules become more complex in their properties, often with low aqueous solubility, nano-phase formulations are becoming more common. These include, for example, a self-assembling delivery systems like micelles and lipids.

Successful formulation strategies will require the extensive application of analytical chemistry methods, to monitor the blending of multiple chemical components together. The elemental and molecular purity of these various components will be a critical quality concern that can be addressed by the use of fluorescence and spectroscopic analytical methods. Throughout the blending and manufacturing process, the solid form structure of the active ingredient will also typically require monitoring by diffraction methods to ensure that polymorph conversion will not be induced by each process step. Furthermore, with multiple chemical components together, the exposure to humidity, temperature, and light may cause complex interactions that impact the therapeutic performance. Non-ambient and thermal methods can be employed to explore the phase relationships between components to help identify any future problems.

Formulation development is a complex art with many potential paths to the target product performance and many potential pitfalls on the way. Rigaku is here to help you navigate through the complexity with an extensive array of analytical equipment and experience. From atomic purity through molecular identity to structure/microstructure and phase behavior, Rigaku offers unique solutions for the Formulation Scientist.

MiniFlex_KI

 

117788_RAH_PharmalyticalSummit_Accelevent_700x350Logo_R2

A DAY OF EDUCATION AND INSIGHTS FOR PHARMACEUTICAL PROFESSIONALS THROUGHOUT THE PRODUCT DEVELOPMENT LIFECYCLE 

Pharmalytical Summit 2021 is a one-day virtual event exploring the technologies, analysis, and innovation that goes into bringing the pharmaceuticals allowing humanity to live longer, fuller, healthier lives.


The day features presentations and discussions with industry leaders and experts who share insights and education to help bring these life-changing products into the world.

 

Join us on May 26th, 2021 from 8 AM to 8 PM CDT.

FORMULATION AGENDA

RELATED APPLICATIONS

palladium_catalyst_in_pharmaceuticals

PALLADIUM CATALYST IN PHARMACEUTICALS

EXPLORE
B-XRD1129_Variable_humidity_measurement_of_a_drug_substance_using_XRD-DSC_and_a_humidity_controller_ApplicationNote_R0423en

VARIABLE HUMIDITY MEASUREMENT OF A DRUG SUBSTANCE USING XRD-DSC AND A HUMIDITY CONTROLLER

EXPLORE

Differential scanning calorimetry (DSC) combined with XRPD and Ka1 Johansson configuration for indexing

Routine Powder XRD Measurement with the XtaLAB Synergy-S, Single Crystal Diffractometer

The use of easy XRF elemental analyses techniques to support the development of formulations

Roundtable Discussion - Polymorphs Throughout the Pharmaceutical Development Lifecycle

QUICK DEMO VIDEO

Blue Accent Line

Excipients App Note 2014Nov14

PHARMACEUTICAL EXCIPIENTS IDENTIFICATION

EXPLORE
Excipients App Note 2014Nov14

REGULATION OF RAW MATERIAL IDENTIFICATION IN COSMETICS

EXPLORE

INDUSTRY-LEADING SUPPORT

OUR COMMITMENT TO CUSTOMERS

  • 24/7 PHONE SUPPORT
  • IQ/OQ/PQ PROGRAM
  • SOP DEVELOPMENT
    CONTACT SERVICE

MADE IN THE USA

FOCUSED CUSTOMER SUPPORT

RECOMMENDED PRODUCT

PROGENY HANDHELD 1064 nm Raman

Progeny Polysorbate Result-resized-B

Versatile Spectrometer for Raw Material Identification and Verification

LEARN MORE

CUTTING-EDGE TECHNOLOGY

HANDHELD 1064 nm RAMAN SPECTROSCOPY

FEATURES & BENEFITS

  • NONDESTRUCTIVE
  • ANALYZE SOLIDS, LIQUIDS, POWDERS, GELS, PASTES AND MORE
  • SCAN THROUGH COLORED PACKAGING
  • ANALYZE COLORED SUBSTANCES
  • RESULTS < 1 MINUTE
  • MINIMIZED FLUORESCENCE

HOW WE WORK WITH YOU

Videos_Icon From Rigaku Global Site

1 - SEE HOW IT WORKS

LIVE AND RECORDED VIRTUAL DEMOS AVAILABLE

GET A DEMO
Sale_Icon

2 - REQUEST A QUOTE

MULTI-UNIT DISCOUNTS AVAILABLE

GET A QUOTE
Handshake_Icon

3 - PURCHASE

PAYMENTS ACCEPTED: 
CREDIT CARD
BANK TRANSFER
PURCHASE ORDER 

SUBMIT NOW

TRUSTED PARTNER

Based in Wilmington, Massachusetts, USA since 2011, Rigaku is a pioneer in handheld 1064 nm Raman and LIBS-based technology for materials analysis. With thousands of units in use globally, our portfolio offers the most versatile solution for use in safety and security against chemical threats, pharmaceutical manufacturing, and in the recycling and quality control of metal alloys. 

We strive to deliver quality, reliability and engaged expertise to our customers. We are dedicated to continuous product development efforts to deliver mission-critical enhancements to performance and functionality, while delivering reliable and cost-effective solutions for results, anywhere.

Rigaku Analytical Devices is an ISO 9001:2015 certified facility.